Centrica plc (LON:CNA - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 155.71 ($2.11) and traded as high as GBX 157.35 ($2.13). Centrica shares last traded at GBX 156.70 ($2.12), with a volume of 16,329,565 shares traded.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. Royal Bank Of Canada increased their price target on shares of Centrica from GBX 175 to GBX 200 and gave the stock an "outperform" rating in a research note on Tuesday, July 29th. JPMorgan Chase & Co. raised their target price on shares of Centrica from GBX 177 to GBX 179 and gave the company a "neutral" rating in a research note on Friday, August 15th. Finally, Citigroup reissued a "buy" rating and issued a GBX 185 target price on shares of Centrica in a research note on Friday, August 15th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of GBX 178.50.
View Our Latest Analysis on Centrica
Centrica Stock Performance
The stock's fifty day moving average is GBX 160.55 and its two-hundred day moving average is GBX 155.71. The firm has a market capitalization of £7.38 billion, a price-to-earnings ratio of -3,406.52, a price-to-earnings-growth ratio of 0.45 and a beta of 1.08. The company has a debt-to-equity ratio of 66.48, a quick ratio of 0.40 and a current ratio of 1.77.
Centrica (LON:CNA - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The integrated energy company reported GBX 7 earnings per share for the quarter. Centrica had a net margin of 5.39% and a return on equity of 25.16%.
Insiders Place Their Bets
In other Centrica news, insider Chris OShea sold 770,946 shares of the firm's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of GBX 168, for a total transaction of £1,295,189.28. Also, insider Philippe Boisseau acquired 1,028 shares of the firm's stock in a transaction on Tuesday, August 26th. The shares were bought at an average cost of GBX 164 per share, with a total value of £1,685.92. Over the last ninety days, insiders have purchased 3,454 shares of company stock valued at $565,909. Company insiders own 0.34% of the company's stock.
Centrica Company Profile
(
Get Free Report)
Centrica is energising a greener, fairer future for our colleagues, customers and communities. Our integrated business operates across the energy value chain, with over ten million Retail customers, leading brands such as British Gas and Bord Gáis Energy, and the UK's largest energy services workforce.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Centrica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centrica wasn't on the list.
While Centrica currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.